Potential pharmaceutical risks (PPRs) and pharmaceutical care issues (PCIs)
Assessing the pharmaceutical care issues of hospitalised epileptic patients
... This association is important in overcoming the DRP issues of poor kowledge and adherence to medication. Side-effects or adverse drug effects are DRP issues can lead to poor adherence. Pharmacist can ...
7
Risks for the Swiss Pharmaceutical Market in 2013
... Sales development by business area • Professional Diagnostics: sales rose 6%, resulting from growth in the immunoassay business (+12%), clinical chemistry testing (+3%) and patient coagulation monitoring (+7%). Four new ...
27
Compliance issues for pharmaceutical companies in Germany
... the pharmaceutical industry and other members of the health care sector, in particular doctors and clinics, has repeatedly been under critical review with regard to possible corruption ...new ...
8
Pharmaceutical supply chain risks: a systematic review
... 12 risks re- lated to supply chain risk were ...to pharmaceutical indus- try, but risks were mentioned in this article could extend to pharmaceutical supply chain and helpful for risk man- ...
7
Improving Pharmaceutical Care in Care Homes
... to care home ...the care home staff had not advised the community pharmacy of obsolete items on the MAR ...reduced potential for medication ...
44
Managed Care and the Pharmaceutical Industry
... If pharmaceutical companies remain independent in the face of managed care, these small corporations will be at risk because of difficulties in finding a market for their ...increased risks of ...
20
Pharmaceutical care issues encountered by post‐menopausal osteoporotic women prescribed bisphosphonates
... Three methods were used to assess medication adherence: direct- reporting (by asking the participant, ‘How many doses of alendr- onate/risedronate did you miss since the last time we met?’), pill count (by counting the ...
8
Pharmaceutical care issues identified by pharmacists in patients with diabetes, hypertension or hyperlipidaemia in primary care settings
... primary care patients with chronic ...the care- giver involved, especially in a community ...Although care has been taken to be as accurate as possible in the classifica- tion, some ambiguities could ...
10
Evaluation of Different Types of Risks in Pharmaceutical Supply- Chain
... for Pharmaceutical Supply Chain Risks CONCLUSION In this atmosphere of high competition and increasing business targets pharmaceutical industry faces an array of risk ranging from regulatory failure, ...
8
Current Issues in Pharmaceutical and Medical Device Litigation
... Health Care Division, Office of the Massachusetts Attorney General, Boston, MA Lexi Hazam, Lieff Cabraser Heimann & Bernstein, LLP, San Francisco, CA Alessandro Martuscelli, Shire Human Genetic Therapies, ...
11
Some issues for pharmaceutical companies under the FCPA
... V� GSK in China GSK recently got into anti-corruption hot water for another set of bribery schemes in China. In an FT article, entitled “Bribery built into the fabric of Chinese healthcare system”, reporters Jamil ...
6
SMARTPHONE APPLICATIONS FOR IMPROVED PHARMACEUTICAL CARE
... specifically themed to major vascular diseases were evaluated and reviewed for their possible integration into practice. It concluded that the integration of smart phone applications into the delivery of medical ...
7
Search strategies. Appendix to report. Benefits and risks. Pharmaceutical treatment in forensic psychiatric care. found
... TX (antipsychotic* or clozapine or risperidone or haloperidol or levomepromazine or chlorpromazine or perphenazine or ziprasidone or flupentixol* or chlorprothixene or zuclopenthixol* or[r] ...
63
REALIZING THE TRUE POTENTIAL OF THE PHARMACEUTICAL MARKET IN INDIA
... Indian companies have also started entering into the realm of R&D; some of the leading local producers have now started conducting original research. India has the world‟s second biggest pool of English speakers and a ...
16
Potential Impact on the Generic Pharmaceutical Industry in Canada
... generic pharmaceutical industry is a good candidate for industrial development by countries that wish to attract and retain its industrial ...generic pharmaceutical investors are preparing for future growth ...
31
Pharmaceutical Marketing & Economic issues: Drug copay subsidies ( coupons ) and potential consumer and State interests
... Community Catalyst is a national non-profit health advocacy organization working to ensure that everyone has access to high-quality, affordable health care.. • Collaborates with nation[r] ...
26
Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication
... 4.2.1. Risks for misuse and diversion It seems plausible that patients with severe cancer pain are at comparatively low risk of diverting their own ...Palliative Care Clinic in Kerala, India 91 involved the ...
114
Pharmaceutical Summit on Business and Compliance Issues in Managed Markets
... health care system has been moving rapidly toward paying for value, payments for drugs largely continue to be stuck in a 20th century construct that focuses on price, regardless of the health outcomes of each ...
8
Pharmaceutical Inventory Management Issues in Hospital Supply Chains
... Abstract The primary focus of the healthcare sector is to provide patients with the best quality of care. While the healthcare cost is keep on growing, effective healthcare supply chain should be achieved to ...
5
Health Care Fraud Liability for Pharmaceutical Manufacturers
... to pharmaceutical marketing practices ...other pharmaceutical company practices implicated in discussions of health care ...health care providers, sponsorship of educational programs, and ...
42